BI Asset Management Fondsmaeglerselskab’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Buy |
717,544
+122,858
| +21% | +$8M | 0.46% | 49 |
|
|
2025
Q1 | $43.7M | Sell |
594,686
-303,064
| -34% | -$22.3M | 0.49% | 38 |
|
|
2024
Q4 | $58.8M | Buy |
+897,750
| New | +$58.8M | 0.62% | 32 |
|
|
2024
Q3 | – | Sell |
-453,264
| Closed | -$35.4M | – | 607 |
|
|
2024
Q2 | $35.4M | Buy |
453,264
+39,880
| +10% | +$3.11M | 0.58% | 34 |
|
|
2024
Q1 | $28M | Buy |
413,384
+97,780
| +31% | +$6.62M | 0.53% | 48 |
|
|
2023
Q4 | $21.3M | Buy |
315,604
+4,825
| +2% | +$325K | 0.45% | 62 |
|
|
2023
Q3 | $21M | Sell |
310,779
-21,430
| -6% | -$1.45M | 0.49% | 55 |
|
|
2023
Q2 | $23.8M | Sell |
332,209
-45,403
| -12% | -$3.25M | 0.56% | 47 |
|
|
2023
Q1 | $26.2M | Sell |
377,612
-4,992
| -1% | -$346K | 0.7% | 41 |
|
|
2022
Q4 | $25.9M | Sell |
382,604
-24,627
| -6% | -$1.67M | 0.69% | 36 |
|
|
2022
Q3 | $22.3M | Buy |
407,231
+62,263
| +18% | +$3.41M | 1.14% | 20 |
|
|
2022
Q2 | $22.8M | Sell |
344,968
-33,796
| -9% | -$2.23M | 0.97% | 25 |
|
|
2022
Q1 | $25.1M | Sell |
378,764
-101
| -0% | -$6.7K | 0.96% | 24 |
|
|
2021
Q4 | $22.1M | Buy |
378,865
+18,543
| +5% | +$1.08M | 0.81% | 38 |
|
|
2021
Q3 | $21.6M | Sell |
360,322
-9,016
| -2% | -$542K | 0.82% | 33 |
|
|
2021
Q2 | $22.1M | Sell |
369,338
-29,477
| -7% | -$1.77M | 0.85% | 31 |
|
|
2021
Q1 | $19.8M | Sell |
398,815
-108,352
| -21% | -$5.39M | 0.81% | 35 |
|
|
2020
Q4 | $25.4M | Buy |
+507,167
| New | +$25.4M | 1.1% | 29 |
|